If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Increasing diabetes care awareness, wider insurance coverage and preference for devices that do not need finger pricks have ...

Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...

Insulin Pumps MarketThe Insulin Pumps Market revenue were estimated at USD 5.5 Billion in 2022 and is anticipated to grow at a CAGR of 10.3% from 2022 to 2032, according to a recently published Future ...

We hear all about the national trend: how women from coast to coast are using weight loss medications like Ozempic and Wegovy ...

Abbott Laboratories (ABT) reports robust sales growth in key segments despite challenges in nutrition and diagnostics.

The Government has announced a £15m funding initiative to support the creation of up to 300 new or expanded school-based ...

In our recent paper, “Does REDs exist?”, we raise some important questions about the REDs concept and supporting evidence (1) ...